REMICADE POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100 mg/vial
Product details
Registration number: SIN12120P
Classification: Prescription Only
Active ingredients: INFLIXIMAB
Strength: 100 mg/vial
Dosage form: INJECTION, POWDER, FOR SOLUTION
Route: INTRAVENOUS
Registrant: JOHNSON & JOHNSON INTERNATIONAL (SINGAPORE) PTE LTD
ATC code: L04AB02
HSA approval date: 11 November 2002
Manufacturer(s):
- Patheon Italia S.p.A.
- CILAG AG
- MSD INTERNATIONAL GMBH (SINGAPORE BRANCH)
Manufacturing country/countries: SINGAPORE; SWITZERLAND; ITALY
What are the HSA registration number and classification for REMICADE POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100 mg/vial?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN12120P
Classification: Prescription Only
What active ingredients and strength are recorded for REMICADE POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100 mg/vial?
According to the HSA dataset updated 7 August 2026:
Active ingredients: INFLIXIMAB
Strength: 100 mg/vial
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for REMICADE POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100 mg/vial?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, POWDER, FOR SOLUTION
Route: INTRAVENOUS
Who is the recorded registrant for REMICADE POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100 mg/vial?
According to the HSA dataset updated 7 August 2026:
Registrant: JOHNSON & JOHNSON INTERNATIONAL (SINGAPORE) PTE LTD
Which manufacturers and countries are listed for REMICADE POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100 mg/vial?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- Patheon Italia S.p.A.
- CILAG AG
- MSD INTERNATIONAL GMBH (SINGAPORE BRANCH)
Manufacturing country/countries: SINGAPORE; SWITZERLAND; ITALY
Where can I look up REMICADE POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100 mg/vial in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN12120P or the exact product name REMICADE POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100 mg/vial. The general register link does not preselect this product.
What are the source dates for this REMICADE POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100 mg/vial record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this REMICADE POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100 mg/vial record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN12120P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)